912
Participants
Start Date
January 31, 2010
Primary Completion Date
January 31, 2011
Study Completion Date
April 30, 2011
exenatide once weekly
subcutaneous injection, 2mg, once weekly
liraglutide
subcutaneous injection, forced titration to 1.8mg, once daily
Research Site, Buenos Aires
Research site, Mendoza
Research Site, Rosario
Research Site, Box Hill
Research Site, Geelong
Research Site, Keswick
Research Site, Vienna
Research site, Bonheiden
Research Site, Edegem
Research Site, Genk
Research Site, Leuven
Research Site, Liège
Research Site, Charlottetown
Research Site, Gatineau
Research Site, Ottawa
Research Site, Sherbrooke
Research Site, Vancouver
Research Site, Victoria
Research Site, Windsor
Research Site, Winnipeg
Research Site, Brandýs nad Labem
Research Site, Prague
Research Site, Přerov
Research Site, Grenoble
Research Site, Le Creuzot
Research Site, Marseille
Research Site, Paris
Research Site, Poitiers
Research Site, Reims
Research Site, Strasbourg
Research Site, Bad Staffelstein
Research Site, Beckum
Research Site, Biberach
Research Site, Datteln
Research Site, Dresden
Research Site, Essen
Research Site, Ludwigshafen
Research Site, Mainz
Research Site, Meissen
Research Site, Münster
Research Site, Regensburg
Research Site, Riesa
Research Site, Stuttgart
Research Site, Athens
Research Site, Cholargós
Research Site, Pátrai
Research Site, Békéscsaba
Research Site, Budapest
Research Site, Makó
Research Site, Mosonmagyaróvár
Research Site, Nagykanizsa
Research Site, Székesfehérvár
Research Site, Aligarh
Research Site, Bangalore
Research Site, Chennai
Research Site, Coimbatore
Research Site, Hyderabad
Research Site, Indore
Research Site, Karnal/Haryana
Research site, Karnataka
Research Site, Mumbai
Research Site, Pune
Research Site, Beersheba
Research Site, Haifa
Research Site, Jerusalem
Research Site, Raanana
Research Site, Bari
Research Site, Cagliari
Research Site, Catanzaro
Research Site, Chieti
Research Site, Napoli
Research Site, Roma
Research Site, Treviglio
Research Site, Guadalajara
Research Site, México
Research Site, Monterrey
Research Site, Bialystok
Research Site, Krakow
Research Site, Lodz
Research Site, Poznan
Research site, Rzeszów
Research Site, Warsaw
Research site, Bucharest
Research site, Galati
Research site, Iași
Research site, Oradea
Research Site, Bratislava
Research Site, Košice
Research Site, Malacky
Research Site, Martin
Research Site, Halfway House
Research Site, Johannesburg
Research Site, Kempton Park
Research Site, Parktown
Research Site, Pretoria
Research Site, Seoul
Research Site, Ulsan
Research Site, Alicante
Research Site, Alzira
Research Site, Bilbao
Research Site, Madrid
Research Site, Majadahonda
Research Site, Teruel
Research Site, Changhua
Research Site, Taichung
Research Site, Xindian
Research Site, Yung-Kang, Tainan
Research Site, Zhonghe
Lead Sponsor
Eli Lilly and Company
INDUSTRY
AstraZeneca
INDUSTRY